Golden State Equity Partners Astrazeneca PLC Transaction History
Golden State Equity Partners
- $491 Million
- Q1 2025
A detailed history of Golden State Equity Partners transactions in Astrazeneca PLC stock. As of the latest transaction made, Golden State Equity Partners holds 6,455 shares of AZN stock, worth $463,404. This represents 0.1% of its overall portfolio holdings.
Number of Shares
6,455
Previous 5,809
11.12%
Holding current value
$463,404
Previous $380,000
24.74%
% of portfolio
0.1%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,381Shares Held
478MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.33 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.94 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.69 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.72 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.4 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $222B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...